Kinoshita Takahiro, Kaito Akio
Gastric Surgery Division, National Cancer Center Hospital East, Chiba, Japan.
Transl Gastroenterol Hepatol. 2017 May 9;2:43. doi: 10.21037/tgh.2017.04.05. eCollection 2017.
Laparoscopic radical gastrectomy with lymph node dissection has widely penetrated to East Asian countries, where incidence of gastric cancer occurrence is higher than the rest of the world. Laparoscopic distal gastrectomy for cStageI disease is regarded as one of the option in daily practice in the latest Japanese guidelines; however its applicability to more advanced disease (Stage II/III) is still under debate. Actually, operative techniques of laparoscopic D2 dissection is being matured, but still, necessity of total omentectomy, splenic hilar dissection, management of bulky nodes or large primary tumor, high-level anastomosis in esophageal invasion cases, and extensive peritoneal lavage can be raised as technical limitations. In the future perspective, further technological innovation, including next generation surgical robot, may help surgeons overcome these difficulties. Currently, three large-scaled randomized phase-III clinical trials are ongoing in East Asia, in which patients' accruals have been already completed. With coming long-term outcomes of these well-designed studies, oncological validity of laparoscopic approach will be adequately elucidated.
腹腔镜根治性胃切除术加淋巴结清扫术已广泛传播至东亚国家,这些国家的胃癌发病率高于世界其他地区。在最新的日本指南中,腹腔镜下远端胃癌切除术治疗I期疾病被视为日常实践中的一种选择;然而,其在更晚期疾病(II/III期)中的适用性仍存在争议。实际上,腹腔镜D2淋巴结清扫术的手术技术正在成熟,但总网膜切除术、脾门淋巴结清扫、处理肿大淋巴结或巨大原发性肿瘤、食管侵犯病例的高位吻合以及广泛的腹腔灌洗等操作的必要性仍可被视为技术限制。从未来的角度来看,包括下一代手术机器人在内的进一步技术创新可能有助于外科医生克服这些困难。目前,东亚正在进行三项大规模的随机III期临床试验,患者招募工作已经完成。随着这些精心设计研究的长期结果的出现,腹腔镜手术方法的肿瘤学有效性将得到充分阐明。